SCHEMBL20123074

SCHEMBL20123074

Cc1nccc2c3cc(Cl)cc(-c4cnn(Cc5cccnc5)c4)c3n(CC3CC3)c12

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.39
ADORA2A P29274 5/20 0.37
ADORA2B P29275 5/20 0.37
ADORA1 P30542 5/20 0.37
ADORA3 P0DMS8 3/20 0.37
ALK Q9UM73 2/20 0.36
PIM1 P11309 1/20 0.36
CREBBP Q92793 4/20 0.35
ABL1 P00519 1/20 0.34
BCR P11274 1/20 0.34
JAK1 P23458 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
CRHR1 P34998 1/20 0.34
CRHR2 Q13324 1/20 0.34
DYRK1A Q13627 1/20 0.33
MDM2 Q00987 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30664188 1.00 L3MBTL1 (0.39) L3MBTL1ADORA2AADORA2BADORA1ADORA3
SCHEMBL29756420 0.89 L3MBTL1 (0.42) L3MBTL1ALKCREBBPABL1BCR
SCHEMBL20122987 0.89 L3MBTL1 (0.42) L3MBTL1ALKCREBBPABL1BCR
SCHEMBL29756304 0.86 L3MBTL1 (0.41) L3MBTL1ADORA2AADORA2BADORA1ADORA3
SCHEMBL20122884 0.86 L3MBTL1 (0.41) L3MBTL1ADORA2AADORA2BADORA1ADORA3
SCHEMBL30664313 0.82 CREBBP (0.43) L3MBTL1ADORA2AADORA2BADORA1ADORA3
SCHEMBL20122973 0.82 CREBBP (0.43) L3MBTL1ADORA2AADORA2BADORA1ADORA3
SCHEMBL20122937 0.80 BRD4 (0.37) ABL1CRHR1CRHR2DYRK1A
SCHEMBL30664292 0.80 BRD4 (0.37) ABL1CRHR1CRHR2DYRK1A
SCHEMBL20122709 0.79 L3MBTL1 (0.40) L3MBTL1ALKCREBBPABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2021-09-28 US disclosed
EP-3792262-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2021-03-17 EP disclosed
EP-3792262-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2021-03-17 EP disclosed
EP-3535263-B1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI SA (FR) 2020-09-30 EP disclosed
EP-3535263-B1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI SA (FR) 2020-09-30 EP disclosed
EP-3318563-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2018-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 L3MBTL1 3291/4885ADORA2A 60/4885ADORA2B 14/4885
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 L3MBTL1 3291/4885ADORA2A 60/4885ADORA2B 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.